EMPAVELI's Market Success Underscores Growing Demand for Complement Inhibitor Therapies | DelveInsight
DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a ...
Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device over Impella CP
In a transformative recent study, the Second Heart Assist Inc. Whisper™ device, a next-generation percutaneous mechanical ...
MassDevice8d
Second Heart Assist says Whisper device caused less hemolysis compared to Abiomed Impella CP
Second Heart Assist today announced data from a study highlighting the performance of its Whisper device against a ...
FOX 8 News on MSN7d
Ohio State hospital detecting blood test errors faster with new technology
A major jump in modern medicine for Ohio State’s Wexner Medical Center has arrived. The hospital is among the first in the ...
Morningstar9d
Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device over Impella CP
Analysis was conducted using the tetramethylbenzidine method to measure plasma free hemoglobin, a key indicator of hemolysis. The findings revealed that the Whisper™ not only had a lower change ...
DelveInsight Business Research, LLP: EMPAVELI's Market Success Underscores Growing Demand for Complement Inhibitor Therapies | DelveInsight
EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...
Medscape21h
Heart Failure Care Outside of ICU Can Lower Cost
A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...
NBC4 Columbus7d
Ohio State hospital detecting blood test errors faster with new technology
COLUMBUS, Ohio (WCMH) — A major jump in modern medicine for Ohio State’s Wexner Medical Center has arrived. The hospital is among the first in the country to utilize brand-new technology that ...
Physician's Weekly2d
Q&A: Addressing Renal Disease in Patients With Paroxysmal Nocturnal Hemoglobinuria
Michael Bromberg, MD, PhD, talks with Physician’s Weekly about renal disease in patients with paroxysmal nocturnal ...